LOGO-01.png
Burning Rock Announces US$10 Million Share Repurchase Program
21 juin 2022 02h03 HE | Burning Rock Biotech Limited
GUANGZHOU, China, June 21, 2022 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing...
LOGO-01.png
Burning Rock Announces the Launch of China’s First Prospective Pan-Cancer Multi-omics Early Detection Study
19 mai 2021 05h06 HE | Burning Rock Biotech Limited
BEIJING, May 19, 2021 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”) today announced the launch of the PRESCIENT (Pan-canceR Early-Stage deteCtion by...
LOGO-01.png
Burning Rock to be Added to MSCI China Index
12 mai 2021 04h00 HE | Burning Rock Biotech Limited
GUANGZHOU, China, May 12, 2021 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing...
LOGO-01.png
Burning Rock Announces an Exclusive in-Licensing of a Risk Stratification Test for Early Stage Lung-Cancer Patients from Oncocyte in China
15 déc. 2020 01h33 HE | Burning Rock Biotech Limited
GUANGZHOU, China, Dec. 15, 2020 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”) today announced that it entered into an exclusive licensing agreement...
LOGO-01.png
Burning Rock Announces Pricing of Upsized Registered Secondary Public Offering of American Depositary Shares
04 déc. 2020 06h34 HE | Burning Rock Biotech Limited
GUANGZHOU, China, Dec. 04, 2020 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing...
LOGO-01.png
Burning Rock Announces Proposed Registered Secondary Public Offering of American Depositary Shares
01 déc. 2020 18h47 HE | Burning Rock Biotech Limited
GUANGZHOU, China, Dec. 01, 2020 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing...
LOGO-01.png
Burning Rock Reports Third Quarter 2020 Financial Results
20 nov. 2020 06h00 HE | Burning Rock Biotech Limited
GUANGZHOU, China, Nov. 20, 2020 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing...
LOGO-01.png
Burning Rock Announces In-Licensing of Myriad myChoice® Tumor Testing in China
15 nov. 2020 20h00 HE | Burning Rock Biotech Limited
GUANGZHOU, China, Nov. 15, 2020 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”) today announced that it entered into a development and...
LOGO-01.png
Burning Rock to Present Validation Data of Magnis BR at the AMP Annual Meeting
29 oct. 2020 23h21 HE | Burning Rock Biotech Limited
GUANGZHOU, China, Oct. 29, 2020 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”) today announced that analytical validation data of its fully-automated...
LOGO-01.png
Burning Rock Announces Preliminary Third Quarter 2020 Results and Schedules Earnings Release on November 20, 2020
20 oct. 2020 21h30 HE | Burning Rock Biotech Limited
GUANGZHOU, China, Oct. 20, 2020 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing...